Aiko Shono
Overview
Explore the profile of Aiko Shono including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
100
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Shono A, Morihiro A, Harada N, Seposo X, Mimura W, Hoshi S, et al.
Int J Pharm Pract
. 2025 Feb;
PMID: 39937129
Objective: Testing with fingertip blood sampling, including HbA1c testing, has been available in community pharmacies in Japan since 2014. In 2016, the Mihara Pharmacy Association in Hiroshima Prefecture, in collaboration...
2.
Inano H, Morimoto Y, Kitagawa K, Shibuya A, Nakagomi K, Ota T, et al.
Support Care Cancer
. 2025 Feb;
33(2):149.
PMID: 39904775
Purpose: Our previous study showed that the preventive effects of fosnetupitant (F-NTP) against chemotherapy-induced nausea and vomiting (CINV) were superior to those of fosaprepitant (F-APR) or aprepitant (APR). To evaluate...
3.
Shono A, Hoshi S, Koshida R, Tanaka M, Kondo M
Yakugaku Zasshi
. 2024 Jun;
144(7):749-754.
PMID: 38945849
In Japan, influenza vaccination is offered to children and pregnant women at clinics or hospitals as an elective, self-funded treatment, as the vaccination is not included in the national vaccination...
4.
Inano H, Morimoto Y, Kitagawa K, Shibuya A, Nakagomi K, Ota T, et al.
Biol Pharm Bull
. 2024 Feb;
47(3):692-697.
PMID: 38417893
Existing antiemetic therapy against emetic-risk agents across malignancies 24 h post-dose in the acute period in cisplatin (CDDP)-based regimens yields a satisfactory complete response (CR) rate of ≥90%. However, the...
5.
Hoshi S, Shono A, Seposo X, Okubo R, Kondo M
Vaccine
. 2022 Oct;
40(49):7057-7064.
PMID: 36273987
Background: Despite the 23-valent pneumococcal polysaccharide vaccine (PPSV23) vaccination programme implementation, pneumococcal disease (PD) remains an important cause of morbidity and mortality among the elderly in Japan, particularly since childhood...
6.
Hoshi S, Okubo R, Tabuchi K, Seposo X, Shono A, Kondo M
Vaccine
. 2022 Aug;
40(37):5513-5522.
PMID: 35965241
Background: The most common preventative measure against mumps is vaccination with mumps vaccine. Over 122 countries have implemented mumps vaccine routine immunization programs, mostly via Measles-Mumps-Rubella (MMR) vaccine. In Japan,...
7.
Oki T, Ishii S, Furukawa K, Shono A, Akazawa M
J Pharm Health Care Sci
. 2021 Dec;
7(1):47.
PMID: 34865656
Background: Clinical pharmacists play a role in limiting the disadvantages of pharmacotherapy for patients by detecting and resolving drug-related problems (DRPs) through medication reviews. Although their contributions to patient care...
8.
Gunsmaa G, Shono A, Price P, Kondo M, Hebron C, Potokar T, et al.
Burns
. 2021 Jun;
48(2):381-389.
PMID: 34092419
The majority of pediatric burns in Mongolia occur within the home, particularly in the spaces dedicated to cooking. This makes home environment modification a priority for injury prevention. Many of...
9.
Hoshi S, Shono A, Seposo X, Okubo I, Kondo M
Vaccine
. 2020 Oct;
38(46):7363-7371.
PMID: 33020012
Background: Pregnant women and infants are known as high risk groups for influenza. WHO recommend pregnant women be vaccinated with inactivated influenza vaccine. In Japan, some municipalities started to give...
10.
Shono A, Kondo M, Hoshi S, Okubo R, Yahagi N
Res Social Adm Pharm
. 2020 Apr;
17(2):368-371.
PMID: 32284300
In Japan, a new opportunistic community-based walk-in HbA1c testing program at pharmacies was enabled in 2014. An economic evaluation of this program from societal perspective has previously been published. This...